stella
beta
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder — Stella
Recruiting
Back to Familial Platelet Disorder trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
MD Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov